Critically, in the multiple clinical investigations contained in Table 1, disease conditions involving heme oxygenase-1 generated CO as detected by increased carboxyhemoglobin concentrations were found to have plasmatic hypercoagulation that could not be enhanced to the same degree by exposure of the plasma to CORM-2 compared to normal subjects’ plasma. This evidence concerns the gene HMOX1 and thrombophilia.